JP2023542879A5 - - Google Patents
Info
- Publication number
- JP2023542879A5 JP2023542879A5 JP2023517259A JP2023517259A JP2023542879A5 JP 2023542879 A5 JP2023542879 A5 JP 2023542879A5 JP 2023517259 A JP2023517259 A JP 2023517259A JP 2023517259 A JP2023517259 A JP 2023517259A JP 2023542879 A5 JP2023542879 A5 JP 2023542879A5
- Authority
- JP
- Japan
- Prior art keywords
- months
- population
- treated
- pharmaceutical product
- product according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063080013P | 2020-09-17 | 2020-09-17 | |
| US63/080,013 | 2020-09-17 | ||
| US202163196641P | 2021-06-03 | 2021-06-03 | |
| US63/196,641 | 2021-06-03 | ||
| US202163240794P | 2021-09-03 | 2021-09-03 | |
| US63/240,794 | 2021-09-03 | ||
| PCT/US2021/050627 WO2022060955A1 (en) | 2020-09-17 | 2021-09-16 | Methods for treating cancers with antibody drug conjugates (adc) that bind to 191p4d12 proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023542879A JP2023542879A (ja) | 2023-10-12 |
| JP2023542879A5 true JP2023542879A5 (enExample) | 2024-09-11 |
Family
ID=80777582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023517259A Pending JP2023542879A (ja) | 2020-09-17 | 2021-09-16 | １９１ｐ４ｄ１２タンパク質に結合する抗体薬物複合体（ａｄｃ）を用いたがんの治療方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230330251A1 (enExample) |
| EP (1) | EP4213888A4 (enExample) |
| JP (1) | JP2023542879A (enExample) |
| KR (1) | KR20230091885A (enExample) |
| AU (1) | AU2021344976A1 (enExample) |
| CA (1) | CA3194339A1 (enExample) |
| IL (1) | IL301163A (enExample) |
| MX (1) | MX2023003059A (enExample) |
| PH (1) | PH12023550745A1 (enExample) |
| TW (1) | TWI911277B (enExample) |
| WO (1) | WO2022060955A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA202191201A1 (ru) | 2018-12-03 | 2022-01-26 | Эдженсис, Инк. | Фармацевтические композиции, включающие конъюгаты анти-191p4d12 антитело-лекарственное средство, и способы их применения |
| KR20230106607A (ko) * | 2020-10-11 | 2023-07-13 | 어젠시스 인코포레이티드 | 191p4d12 단백질에 결합하는 항체 약물 접합체(adc)로 암을 치료하는 방법 |
| CA3253030A1 (en) * | 2022-06-01 | 2023-12-07 | ALX Oncology Inc. | Polytherapy for the treatment of urothelial carcinoma |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2874306T3 (es) * | 2010-09-29 | 2021-11-04 | Agensys Inc | Conjugados de anticuerpos y fármacos (CAF) que se unen a las proteínas 191P4D12 |
| RU2021110369A (ru) * | 2017-09-07 | 2021-06-01 | Драгонфлай Терапьютикс, Инк. | Белки, связывающие nkg2d, cd16 и опухолеассоциированный антиген |
| WO2019095017A1 (en) * | 2017-11-17 | 2019-05-23 | Gmdx Co Pty Ltd | Systems and methods for predicting the efficacy of cancer therapy |
| CN109504660B (zh) * | 2018-11-02 | 2021-08-06 | 温州启星生物技术有限公司 | 一种第四代car-t细胞及其构建方法和应用 |
| EA202191201A1 (ru) * | 2018-12-03 | 2022-01-26 | Эдженсис, Инк. | Фармацевтические композиции, включающие конъюгаты анти-191p4d12 антитело-лекарственное средство, и способы их применения |
| US20230025600A1 (en) * | 2019-11-25 | 2023-01-26 | Agensys, Inc. | Treatment of cancers with antibody drug conjugates (adc) that bind to 191p4d12 proteins |
-
2021
- 2021-09-16 JP JP2023517259A patent/JP2023542879A/ja active Pending
- 2021-09-16 CA CA3194339A patent/CA3194339A1/en active Pending
- 2021-09-16 PH PH1/2023/550745A patent/PH12023550745A1/en unknown
- 2021-09-16 KR KR1020237012738A patent/KR20230091885A/ko active Pending
- 2021-09-16 EP EP21870200.9A patent/EP4213888A4/en active Pending
- 2021-09-16 AU AU2021344976A patent/AU2021344976A1/en active Pending
- 2021-09-16 US US18/025,349 patent/US20230330251A1/en active Pending
- 2021-09-16 MX MX2023003059A patent/MX2023003059A/es unknown
- 2021-09-16 WO PCT/US2021/050627 patent/WO2022060955A1/en not_active Ceased
- 2021-09-16 IL IL301163A patent/IL301163A/en unknown
- 2021-09-16 TW TW110134601A patent/TWI911277B/zh active